The role of adding spironolactone and renal denervation in true resistant hypertension. one-year outcomes of randomized study.

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Resistant hypertension Treatment of hypertension ESC Premium Access ESC Congress 2016

ESC 365 is supported by

ESC 365 is supported by